Navigation Links
NeuroPhage Awarded Second Grant from Michael J. Fox Foundation for Parkinson's Disease Research
Date:12/19/2013

CAMBRIDGE, Mass., Dec. 19, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced that it has been awarded an $822,000 grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF) for its second-generation drug candidate, NPT088, based on NeuroPhage's GAIM (general amyloid interaction motif) platform, which simultaneously targets multiple misfolded proteins central to many neurodegenerative diseases. In particular, the MJFF grant will be applied to research the effect of NPT088 on alpha-synuclein deposits in the brain, a pathological hallmark of Parkinson's disease (PD). This is NeuroPhage's second grant from MJFF applied to the GAIM platform.

"NeuroPhage is honored to receive its second grant from the MJFF, which supports our GAIM platform as a unique approach to the treatment of PD and other neurodegenerative diseases characterized by deposits of misfolded proteins. This award will allow us to make continued progress on our program in PD with our second-generation candidate, NPT088, continuing to build on our strong preclinical data," said Kimberley S. Gannon, PhD, Senior Vice President of Preclinical R&D at NeuroPhage.

The proceeds of the new MJFF grant will be used to test the effect of NPT088 on alpha-synuclein accumulation in the brain in a preclinical model of PD. The preclinical study will be conducted in collaboration with Dr. Eliezer Masliah at the University of California, San Diego. NeuroPhage previously demonstrated that a single treatment of NPT001, a first-generation GAIM molecule, produced significant reductions in neuropathology along with improved motor performance in preclinical PD models.

"We are pleased with the progress that NeuroPhage has made since our original collaboration began in June 2011 under a Therapeutics Development Initiative Award," said Kuldip Dave, PhD, Senior Associate Director of Research Programs at MJFF.
'/>"/>

SOURCE NeuroPhage Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
2. NeuroPhage Extends Series B to $21.4M
3. K computer research results awarded ACM Gordon Bell Prize
4. BioPower Systems Awarded $5 Million from Victorian Government
5. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
6. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
9. EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics
10. Sloan Research Fellowships Awarded to 126 Young Scholars
11. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... North Shore Towers, a luxury co-op community based ... one of the nation’s leading combined heating and power (CHP) ... 43-year-old CHP system. The original CHP system had been maintained ... the life of the plant, GI Energy was contracted to ... recovery equipment, while maintaining continuous operation of the entire complex. ...
(Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
(Date:7/31/2014)... July 31, 2014 Senomyx , ... company using proprietary taste science technologies to discover, ... food, beverage, and ingredient supply industries, today reported ... Company ended the second quarter with $33.6 million ... "During the past quarter Senomyx achieved another ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 ... an Irys™System by BGI , the ... enable comprehensive exploration of human structural variation (SV) and ... interest, including those where no reference exists. In addition, ... methods for multiplexing on the Irys System, enabling significantly ...
Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... 2011 Sigma Life Science, the innovative biological ...  SIAL), and King,s College London, today announced an ... for the identification and validation of microRNA (miRNA) ... detailed information, visit www.wherebiobegins.com/targetid . ...
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0489604/Genetics-Reports-Bundle.html Report Description ... TriMark Publications reports at a15% discount off the individual reports being ... DNA Sequencing and PCR Markets. - Gene Expression ...
... Highlights First Quarter 2011: First ... to Alexandria Real Estate Equities, Inc.,s Common Stockholders of $1.15, ... Up 6% Compared to First Quarter 2010 FFO Per Share ... (Diluted) Attributable to Alexandria Real Estate Equities, Inc.,s Common Stockholders ...
Cached Biology Technology:Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 2Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 3Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 4Reportlinker Adds Genetics Reports Bundle 2Reportlinker Adds Genetics Reports Bundle 3Reportlinker Adds Genetics Reports Bundle 4Reportlinker Adds Genetics Reports Bundle 5Reportlinker Adds Genetics Reports Bundle 6Reportlinker Adds Genetics Reports Bundle 7Reportlinker Adds Genetics Reports Bundle 8Reportlinker Adds Genetics Reports Bundle 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 2Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 3Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 4Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 5Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 6Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 7Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 10Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 11Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 12Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 13Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 14Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 15Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 16
(Date:8/1/2014)... the UC Davis Center for Neuroscience and Department ... and Engineering Faculty Fellowship from the U.S. Department ... support new work on learning and memory in ... The new project aims to connect neural oscillations, ... the cortex and hippocampus, brain regions that are ...
(Date:8/1/2014)... marine mammals have officially named a species new ... sahulensis , according to the Wildlife Conservation Society ... the newly named species is the culmination of ... historical records, physical descriptions, and genetic data of ... from the coast of West Africa to the ...
(Date:8/1/2014)... in stem cell research will provide enormous opportunities ... stem cells could replicate any other cells in ... disease, repairing damaged spinal cords, treating kidney, liver ... The potential for profit is staggering. Prof. Jinhui ... this field of research still faces myriad biological, ...
Breaking Biology News(10 mins):Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3
... (PHILADELPHIA) Scientists at Jefferson Medical College have received ... funded by the National Heart, Lung and Blood Institute ... of platelet gene expression. The study aims to find ... strategies and develop better predictors of cardiovascular disease. ...
... Researchers have tracked a cell-to-cell signaling pathway that designates ... embryonic mice. The scientists succeeded in activating this signal ... inner ear. Patches of sensory structures began growing in ... structures contained tufted cells, called hair cells, which respond ...
... New ground broken by Michigan State University biochemists ... temperatures and could lead to discoveries related to ... "This brings together two classic problems in ... biochemistry and molecular biology. "One is that plants ...
Cached Biology News:Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets 2Tuning into cell signals that tell where sensory organs will form inside the ear 2Tuning into cell signals that tell where sensory organs will form inside the ear 3Researchers discover novel mechanism protecting plants against freezing 2
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
... the simple, phenol-free extraction of genomic DNA ... proteinase K digestion.Each kit is designed to ... of up to 25 mg of hard ... and Amplification of Genomic DNA, Nucleon DNA ...
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Biology Products: